🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12361+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12361 recruiting trials

NARecruitingNCT06277401

Exercise in Patients With Hypermobile Joints and Knee Pain

👨‍⚕️ Behnam Liaghat, PhD, University of Southern Denmark📍 2 sites📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT06277154

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

👨‍⚕️ Xing Zhang, Sun Yat-Sen University Cancer Center📍 1 site📅 Started Feb 2024View details ↗
Enrolling by InvitationNCT07363980

Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study

👨‍⚕️ Ellen-Margrethe Hauge, MD, PhD, Aarhus University Hospital and Aarhus University📍 4 sites📅 Started Feb 2024View details ↗
RecruitingNCT06405126

Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension

🏥 KU Leuven📍 4 sites📅 Started Feb 2024View details ↗
NARecruitingNCT07192679

MAGNIFY - Pulmonary Magnetic Resonance Imaging for Cystic Fibrosis

👨‍⚕️ Jim Wild, Professor📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT05878041

Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.

👨‍⚕️ Cinzia Perrino, MD pHD, Federico II University📍 1 site📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT06222580

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

👨‍⚕️ Uma M Borate, MD, MS, Ohio State University Comprehensive Cancer Center📍 3 sites📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05896228

Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma

👨‍⚕️ Carl O Landgren, MD, PhD, University of Miami📍 1 site📅 Started Feb 2024View details ↗
NARecruitingNCT06112509

Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery

👨‍⚕️ DAMON Veronique, MD, CHU de Besançon📍 1 site📅 Started Feb 2024View details ↗
EARLY_Phase 1RecruitingNCT06207552

Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease

👨‍⚕️ Hong Xu, MD,PhD, Children's Hospital of Fudan University📍 1 site📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT05998408

JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure

👨‍⚕️ Emma M Groarke, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Feb 2024View details ↗
Phase 4RecruitingNCT05995600

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

👨‍⚕️ Seung-Hoon Lee, MD, PhD, Seoul National University Hospital📍 32 sites📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT06215118

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 43 sites📅 Started Feb 2024View details ↗
RecruitingNCT06268457

Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis

🏥 Istituto Ortopedico Rizzoli📍 1 site📅 Started Feb 2024View details ↗
Phase 1, PHASE2RecruitingNCT06265025

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

👨‍⚕️ SH Lee, Korea University Anam Hospital📍 4 sites📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT06006559

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

🏥 Novartis Pharmaceuticals📍 23 sites📅 Started Feb 2024View details ↗
Phase 1, PHASE2RecruitingNCT05736406

A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

👨‍⚕️ Jan Drappatz, MD, UPMC Presbyterian Shadyside Hospital, Pittsburgh, PA📍 2 sites📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT06227026

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

👨‍⚕️ Sagar Patel, MD, Huntsman Cancer Institute/ University of Utah📍 1 site📅 Started Feb 2024View details ↗
Phase 1, PHASE2RecruitingNCT06185764

A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

🏥 Vertex Pharmaceuticals Incorporated📍 26 sites📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT06210490

A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery

🏥 Peking University First Hospital📍 1 site📅 Started Feb 2024View details ↗
← PreviousPage 325 of 619Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →